中信建投-Innovent Biologics：From China Leadership to Global Premier Biopharma-260617

登录忘记密码注册

>> 中信建投-Innovent Biologics：From China Leadership to Global Premier Biopharma-260617

上传日期：	2026/6/18	大小：	6633KB
格式：	pdf 共71页	来源：	中信建投
评级：	--	作者：	--
下载权限：	此报告为加密报告

相关研报

中信建投-三只松鼠(300783)Exploring multi-format operations such as hard-discount supermarkets and fresh snacks,with a promising business transformation ahead-260617
中信建投-周大福(01929.HK)FY26 fixed-price jewellery drove growth;weight-priced products performed well in April-May,with upbeat FY27 guidance-260617
中信建投-家用电器：Five questions to have a clear understanding of the home appliance business under Hisense Group-260617
中信建投-银行：2026 investment strategy report_Marginal improvement in fundamentals;focus on quality names with dividend appeal-260616
中信建投-杰瑞股份(002353)From oilfield service equipment leader to AI power source newcomer-260616
中信建投-新产业(300832)1Q26 performance under short-term pressure,while the reagent segment maintains stable growth-260616
中信建投-传媒：Domestic Model Series Deep Dive(3)-Moonshot AI(Kimi)_From Long Context to Pioneering Trillion-Parameter Models,Agentic Future in Sight-260616
中信建投-软件与服务：US tech earnings recap_cloud service growth trajectory lifts,software sector logic diverges-260616
中信建投-飞荣达(300602)Deeply engaged in EMI shielding and thermal management,seizing the golden opportunity in AI liquid cooling-260615
中信建投-海西新药(02637.HK)Earnings growth in line with expectations,HXP056 clinical progress continues-260615

Copyright © 2005 - 2021 Nxny.com All Rights Reserved 备案号：蜀ICP备15031742号-1